Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
LSB LakeShore Biopharma
- 1.180
- -0.070-5.60%
Trading May 2 11:56 ET
22.52MMarket Cap-0.42P/E (TTM)
1.260High1.180Low10.27KVolume1.300Open1.250Pre Close12.31KTurnover0.29%Turnover RatioLossP/E (Static)19.08MShares11.20052wk High0.28P/B4.25MFloat Cap1.15052wk Low--Dividend TTM3.60MShs Float263.493Historical High--Div YieldTTM6.40%Amplitude1.150Historical Low1.199Avg Price1Lot Size
LakeShore Biopharma Key Stats
EPS
According to the latest financial report of LakeShore Biopharma, the latest earnings per share (TTM) for the company is -11.33. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Quarterly
Loading...
FCF
Interested in knowing about LakeShore Biopharma's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CNY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of LakeShore Biopharma shows that the company's current ratio is 1.17, indicating healthy liquidity.
Currency: CNY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of LakeShore Biopharma, the quick ratio is 0.79, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Quarterly
Loading...
ROE
Want to learn more about the financial health of LakeShore Biopharma? The latest ROE figure is -17.24%, indicating that the company has stable profitability.
Currency: CNY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of LakeShore Biopharma, the total asset return on investment (ROA) is -6.36%.
Currency: CNY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check LakeShore Biopharma's latest financial report to see how their gross margin is doing - currently at 81.92%.
Currency: CNY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of LakeShore Biopharma, the net profit margin is -108.43%, which is a good sign for its profitability.
Currency: CNY
Quarterly
Loading...
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
